miR‑15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway

Liu,Jie; Xu,Haiyan; Wang,Nan; Sun,Mingyan

doi:10.3892/etm.2020.9352

miR‑15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway

Authors:
- Jie Liu
- Haiyan Xu
- Nan Wang
- Mingyan Sun
View Affiliations

Affiliations: Department of Thoracic Surgery, Shandong Institute of Tumor Control, Shandong Cancer Hospital, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong 250000, P.R. China, The Second Department of Operating Room, Binzhou People's Hospital, Binzhou, Shandong 256610, P.R. China, Laboratory Department, Affiliated Hospital of Weifang Medical College, Weifang, Shandong 261031, P.R. China
Published online on: October 15, 2020 https://doi.org/10.3892/etm.2020.9352
Article Number: 222

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNA (miR)‑15b is an important regulator in several types of cancer, such as gastric cancer, colorectal cancer and oesophageal squamous cell carcinoma. The PI3K/AKT signalling pathway has been implicated in the growth and metastasis of oesophageal cancer (EC). The aim of the present study was to investigate the biological effects of miR‑15b in EC, as well as the underlying mechanism involving the PI3K/AKT signalling pathway. The present study included 74 patients with EC and 74 healthy volunteers. The expression of miR‑15b in peripheral blood mononuclear cells (PBMCs) and EC cell lines was evaluated via reverse transcription‑quantitative PCR. The receiver operating characteristic curve was plotted to determine the diagnostic significance of miR‑15b. EC cell viability, apoptosis, migration and invasion were analysed by conducting MTT, flow cytometry and transwell assays, respectively. Protein expression levels were analysed via western blotting. The results indicated that PBMCs isolated from patients with EC had lower miR‑15b expression levels compared with PBMCs isolated from healthy volunteers. In patients with EC, miR‑15b expression was strongly associated with tumour size, lymph node metastasis, TNM stage, fibrous membrane invasion and histologic grade. The results of the gain/loss‑of‑function in vitro experiments indicated that miR‑15b inhibited EC cell viability, migration and invasion, facilitated EC cell apoptosis and attenuated the PI3K/AKT signalling pathway in EC109 and TE10 cells. Treatment of EC cells with the PI3K/AKT pathway agonist recilisib displayed the opposite effects, blocking the inhibitory function of miR‑15b mimic on EC cell viability, migration and invasion. In summary, the results indicated that miR‑15b suppressed EC cell viability, migration and invasion, and promoted EC cell apoptosis by inhibiting the PI3K/AKT signalling pathway.

View Figures

View References

1	Jia X, Liu P, Zhang M, Feng T, Tang H, Tang Z, Zhao H and Jin T: Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. Int J Clin Exp Med. 8:19381–19387. 2015.PubMed/NCBI
2	Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Sasazuki S, Inoue M and Tsugane S: Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Alcohol drinking and esophageal cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 41:677–692. 2011.PubMed/NCBI View Article : Google Scholar
3	Short MW, Burgers KG and Fry VT: Esophageal cancer. Am Fam Physician. 95:22–28. 2017.PubMed/NCBI
4	Yang C, Shen S, Zheng X, Ye K, Sun Y, Lu Y and Ge H: Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3. FASEB J. 33:10490–10504. 2019.PubMed/NCBI View Article : Google Scholar
5	Lowery AJ, Miller N, McNeill RE and Kerin MJ: MicroRNAs as prognostic indicators and therapeutic targets: Potential effect on breast cancer management. Clin Cancer Res. 14:360–365. 2008.PubMed/NCBI View Article : Google Scholar
6	Guo L and Lu Z: The fate of miRNA* strand through evolutionary analysis: Implication for degradation as merely carrier strand or potential regulatory molecule? PLoS One. 5(e11387)2010.PubMed/NCBI View Article : Google Scholar
7	He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.PubMed/NCBI View Article : Google Scholar
8	Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 99:15524–15529. 2002.PubMed/NCBI View Article : Google Scholar
9	Du G, Zhou J, Cheng L, Ma X, Gui Y and Tan B: High expression of miR-206 predicts adverse outcomes: A potential therapeutic target for esophageal cancer. Comb Chem High Throughput Screen. 22:599–611. 2019.PubMed/NCBI View Article : Google Scholar
10	Wang L, Zhang Z, Yu X, Li Q, Wang Q, Chang A, Huang X, Han X, Song Y, Hu J, et al: SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression. Cancer Lett. 468:14–26. 2020.PubMed/NCBI View Article : Google Scholar
11	Zhang L, Chen J, Wang L, Chen L, Du Z, Zhu L, Cui M, Zhang M and Song L: Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer. J Cell Biochem. 120:19345–19357. 2019.PubMed/NCBI View Article : Google Scholar
12	Chava S, Reynolds CP, Pathania AS, Gorantla S, Poluektova LY, Coulter DW, Gupta SC, Pandey MK and Challagundla KB: MiR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 14:180–196. 2020.PubMed/NCBI View Article : Google Scholar
13	Marcuello M, Duran-Sanchon S, Moreno L, Lozano JJ, Bujanda L, Castells A and Gironella M: Analysis of A 6-Mirna signature in serum from colorectal cancer screening participants as non-invasive biomarkers for advanced adenoma and colorectal cancer detection. Cancers (Basel). 11(1542)2019.PubMed/NCBI View Article : Google Scholar
14	Yuan C, Zhang Y, Tu W and Guo Y: Integrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer. Oncol Lett. 18:1979–1988. 2019.PubMed/NCBI View Article : Google Scholar
15	Wang L, Yu X, Zhang Z, Pang L, Xu J, Jiang J, Liang W, Chai Y, Hou J and Li F: Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9. J Exp Clin Cancer Res. 36(182)2017.PubMed/NCBI View Article : Google Scholar
16	Li CY, Zhang WW, Xiang JL, Wang XH, Li J and Wang JL: Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: A study based on the cancer genome atlas (TCGA) and bioinformatics. Chin Med J (Engl). 132:2213–2222. 2019.PubMed/NCBI View Article : Google Scholar
17	Liu Z, Chen M, Xie LK, Liu T, Zou ZW, Li Y, Chen P, Peng X, Ma C, Zhang WJ and Li PD: CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling. Aging (Albany NY). 10:2570–2584. 2018.PubMed/NCBI View Article : Google Scholar
18	Yang J, Zhang L, Jiang Z, Ge C, Zhao F, Jiang J, Tian H, Chen T, Xie H, Cui Y, et al: TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression. Theranostics. 9:5810–5827. 2019.PubMed/NCBI View Article : Google Scholar
19	Zhang F, Li K, Yao X, Wang H, Li W, Wu J, Li M, Zhou R, Xu L and Zhao L: A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. EBioMedicine. 44:311–321. 2019.PubMed/NCBI View Article : Google Scholar
20	Sheng J, Deng X, Zhang Q, Liu H, Wang N, Liu Z, Dai E and Deng Q: PAR-2 promotes invasion and migration of esophageal cancer cells by activating MEK/ERK and PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 12:787–797. 2019.PubMed/NCBI
21	Song Y, Liu H, Cui C, Peng X, Wang C, Tian X and Li W: Silencing of peroxiredoxin 1 inhibits the proliferation of esophageal cancer cells and promotes apoptosis by inhibiting the activity of the PI3K/AKT pathway. Cancer Manag Res. 11:10883–10890. 2019.PubMed/NCBI View Article : Google Scholar
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Zhang J, Zhou Y, Jiang K, Shen Z, Ye Y and Wang S: Evaluation of the seventh AJCC TNM staging system for gastric cancer: A meta-analysis of cohort studies. Tumour Biol. 35:8525–8532. 2014.PubMed/NCBI View Article : Google Scholar
24	Shimada A, Tsushima T, Tsubosa Y, Booka E, Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, et al: Validity of surgical resection for lymph node or pulmonary recurrence of esophageal cancer after definitive treatment. World J Surg. 43:1286–1293. 2019.PubMed/NCBI View Article : Google Scholar
25	Steffen T, Dietrich D, Schnider A, Kettelhack C, Huber O, Marti WR, Furrer M, Gloor B, Schiesser M, Thierstein S, et al: Recurrence patterns and long-term results after induction chemotherapy, chemoradiotherapy, and curative surgery in patients with locally advanced esophageal cancer. Ann Surg. 269:83–87. 2019.PubMed/NCBI View Article : Google Scholar
26	Matos B, Bostjancic E, Matjasic A, Popovic M and Glavac D: Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: Correlation to treatment, time to recurrence, overall survival and MGMT methylation status. Radiol Oncol. 52:422–432. 2018.PubMed/NCBI View Article : Google Scholar
27	Wen F, Xu JZ and Wang XR: Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma. Arch Gynecol Obstet. 295:743–749. 2017.PubMed/NCBI View Article : Google Scholar
28	Liu Z, Hu G, Zhao Y, Xiao Z, Yan M and Ren M: Silence of cZNF292 suppresses the growth, migration, and invasion of human esophageal cancer Eca-109 cells via upregulating miR-206. J Cell Biochem. 121:2354–2362. 2020.PubMed/NCBI View Article : Google Scholar
29	Lovat F, Fassan M, Sacchi D, Ranganathan P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G, Distefano R, et al: Knockout of both miR-15/16 loci induces acute myeloid leukemia. Proc Natl Acad Sci USA. 115:13069–13074. 2018.PubMed/NCBI View Article : Google Scholar
30	Gottmann P, Ouni M, Saussenthaler S, Roos J, Stirm L, Jähnert M, Kamitz A, Hallahan N, Jonas W, Fritsche A, et al: A computational biology approach of a genome-wide screen connected miRNAs to obesity and type 2 diabetes. Mol Metab. 11:145–159. 2018.PubMed/NCBI View Article : Google Scholar
31	Wang J, Liu H, Tian L, Wang F, Han L, Zhang W and Bai YA: MiR-15b inhibits the progression of glioblastoma cells through targeting insulin-like growth factor receptor 1. Horm Cancer. 8:49–57. 2017.PubMed/NCBI View Article : Google Scholar
32	Weng Y, Shen Y, He Y, Pan X, Xu J, Jiang Y, Zhang Q, Wang S, Kong F, Zhao S, et al: The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect. Biochem Biophys Res Commun. 503:2749–2757. 2018.PubMed/NCBI View Article : Google Scholar
33	Xin QL, Deng CL, Chen X, Wang J, Wang SB, Wang W, Deng F, Zhang B, Xiao G and Zhang LK: Quantitative proteomic analysis of mosquito C6/36 cells reveals host proteins involved in Zika virus infection. J Virol. 91:e00554–17. 2017.PubMed/NCBI View Article : Google Scholar
34	Lu Z, Wu Z, Hu J, Wei W, Ma B and Wen D: MicroRNA-15 regulates the proliferation, migration and invasion of thyroid cancer cells by targeting Bcl-2. J BUON. 24:2114–2119. 2019.PubMed/NCBI
35	Lu L, Li Y, Wen H and Feng C: Overexpression of miR-15b promotes resistance to sunitinib in renal cell carcinoma. J Cancer. 10:3389–3396. 2019.PubMed/NCBI View Article : Google Scholar
36	Pan WY, Zeng JH, Wen DY, Wang JY, Wang PP, Chen G and Feng ZB: Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation. Oncol Lett. 17:1695–1713. 2019.PubMed/NCBI View Article : Google Scholar
37	Shi N, Yu H and Chen T: Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway. Onco Targets Ther. 12:7637–7647. 2019.PubMed/NCBI View Article : Google Scholar
38	Yang SX, Polley E and Lipkowitz S: New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treat Rev. 45:87–96. 2016.PubMed/NCBI View Article : Google Scholar
39	Janku F, Yap TA and Meric-Bernstam F: Targeting the PI3K pathway in cancer: Are we making headway? Nat Rev Clin Oncol. 15:273–291. 2018.PubMed/NCBI View Article : Google Scholar
40	Zheng TL, Li DP, He ZF and Zhao S: miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int. 19(250)2019.PubMed/NCBI View Article : Google Scholar
41	Lin C, Liu A, Zhu J, Zhang X, Wu G, Ren P, Wu J, Li M, Li J and Song L: miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma. Nat Commun. 5(4620)2014.PubMed/NCBI View Article : Google Scholar
42	Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, Liu X, Wang L, Wu L, Chen R, et al: Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. Oncotarget. 8:5735–5752. 2017.PubMed/NCBI View Article : Google Scholar
43	Li GC, Qin XL, Song HH, Li YN, Qiu YY, Cui SC, Wang YS, Wang H and Gong JL: Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3. J Cell Physiol. 234:22331–22342. 2019.PubMed/NCBI View Article : Google Scholar
44	Sun Y, Gao Y, Song T, Yu C, Nie Z and Wang X: MicroRNA-15b participates in the development of peripheral arterial disease by modulating the growth of vascular smooth muscle cells. Exp Ther Med. 18:77–84. 2019.PubMed/NCBI View Article : Google Scholar
45	Park J, Feng J, Li Y, Hammarsten O, Brazil DP and Hemmings BA: DNA-dependent protein kinase-mediated phosphorylation of protein kinase B requires a specific recognition sequence in the C-terminal hydrophobic motif. J Biol Chem. 284:6169–6174. 2009.PubMed/NCBI View Article : Google Scholar
46	Szymonowicz K, Oeck S, Malewicz NM and Jendrossek V: New insights into protein kinase B/Akt signaling: Role of localized Akt activation and compartment-specific target proteins for the cellular radiation response. Cancers (Basel). 10(78)2018.PubMed/NCBI View Article : Google Scholar
47	Porta C, Paglino C and Mosca A: Targeting PI3K/Akt/mTOR Signaling in cancer. Front Oncol. 4(64)2014.PubMed/NCBI View Article : Google Scholar
48	Hu H, Wang F, Wang M, Liu Y, Wu H, Chen X and Lin Q: FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways. Int J Med Sci. 17:807–814. 2020.PubMed/NCBI View Article : Google Scholar